Automated molecular pathology apparatus having fixed slide platforms

Information

  • Patent Grant
  • 7404927
  • Patent Number
    7,404,927
  • Date Filed
    Friday, December 2, 2005
    18 years ago
  • Date Issued
    Tuesday, July 29, 2008
    16 years ago
Abstract
Apparatus and methods for automatically staining or treating multiple tissue samples mounted on slides are provided, in which the slides and reagent bottles are held in fixed position, and the reagent and wash solutions brought to the slides.
Description
FIELD OF THE INVENTION

The present invention is directed to apparatus for use in diagnostic molecular pathology and, more particularly, to such apparatus used for the automated staining and/or treating of tissue samples mounted on microscope slides.


BACKGROUND OF THE INVENTION

Molecular pathology is the examination at a molecular level of the DNA, mRNA, and proteins that cause or are otherwise associated with disease. From this examination important information about patient diagnosis, prognosis, and treatment options can be elucidated. The practice of molecular pathology is generally divided into two main areas: (i) analysis of DNA, mRNA, and proteins in intact cells (in-situ), and (ii) analysis of these biological materials after they have been extracted from tissues. The first category, to which the present invention is primarily directed, has the advantage that it allows the pathologist or scientist to study the histopathologic architecture or morphology of the tissue specimen under the microscope at the same time that the nucleic acid or proteins are being assayed. These techniques include immunohistochemistry (IHC) which looks at proteins, in-situ hybridization (ISH) which looks at nucleic acids, histochemistry (HC) which looks at carbohydrates, and enzyme histochemistry (EHC) which looks at enzyme chemistry. For example, ISH can be used to look for the presence of a genetic abnormality or condition such as amplification of cancer causing genes specifically in cells that, when viewed under a microscope, morphologically appear to be malignant. ISH is also useful in the diagnosis of infectious diseases as it allows detection not only of a microbial sequence but also of precisely which cells are infected. This may have important clinicopathologic implications and is an effective means to rule out the possibility that positive hybridization signal may have come from an adjacent tissue of no clinical concern or from blood or outside contamination.


IHC utilizes antibodies which bind specifically with unique epitopes present only in certain types of diseased cellular tissue. IHC requires a series of treatment steps conducted on a tissue section or cells (e.g. blood or bone marrow) mounted on a glass slide to highlight by selective staining certain morphological indicators of disease states. Typical steps include pretreatment of the tissue section to remove the paraffin and reduce non-specific binding, retrieval of antigens masked by cross-linking of the proteins from the chemical fixatives, antibody treatment and incubation, enzyme labeled secondary antibody treatment and incubation, substrate reaction with the enzyme to produce a fluorophore or chromophore highlighting areas of the tissue section having epitopes binding with the antibody, counterstaining, and the like. Most of these steps are separated by multiple rinse steps to remove unreacted residual reagent from the prior step. Incubations can be conducted at elevated temperatures, usually around 37° C., and the tissue must be continuously protected from dehydration. ISH analysis, which relies upon the specific binding affinity of probes with unique or repetitive nucleotide sequences from the cells of tissue samples or bodily fluids, requires a similar series of process steps with many different reagents and is further complicated by varying temperature requirements.


In view of the large number of repetitive treatment steps needed for both IHC and ISH, automated systems have been introduced to reduce human labor and the costs and error rate associated therewith, and to introduce uniformity. Examples of automated systems that have been successfully employed include the ES®, NexES®, DISCOVERY™, BENCHMARK™ and Gen II® staining Systems available from Ventana Medical Systems (Tucson, Ariz.). These systems employ a microprocessor controlled system including a revolving carousel supporting radially positioned slides. A stepper motor rotates the carousel placing each slide under one of a series of reagent dispensers positioned above the slides. Bar codes on the slides and reagent dispensers permits the computer controlled positioning of the dispensers and slides so that different reagent treatments can be performed for each of the various tissue samples by appropriate programming of the computer.


Instrumentation such as the Ventana Medical Systems ES®, NexES®, BENCHMARK® and DISCOVERY® systems are fundamentally designed to sequentially apply reagents to tissue sections mounted on one by three inch glass microscope slides under controlled environmental conditions. The instrument must perform several basic functions such as reagent application, washing (to remove a previously applied reagent), jet draining (a technique to reduce the residual buffer volume on a slide subsequent to washing), Liquid Coverslip™ application (a light oil application used to contain reagents and prevent evaporation), and other instrument functions.


The Ventana Medical Systems staining instruments mentioned above process slides on a rotating carousel. The instrumentation described herein has the slides fixed in a stationary position and rotates the basic processing stations above the fixed slides. The following details of how the slides are processed, the process algorithm, is the same regardless of the physical configuration.


The process of staining tissue on a slide consists of the sequential repetition of the basic instrument functions described above. Essentially a reagent is applied to the tissue then incubated for a specified time at a specific temperature. When the incubation time is completed the reagent is washed off the slide and the next reagent is applied, incubated, and washed off, etc, until all of the reagents have been applied and the staining process is complete.


It is desirable to permit any staining protocol for any of the slides being run, i.e. any combination of reagents and incubation times. In addition, to stain multiple slides as quickly as possible the instrument should process the slides simultaneously. This is feasible given that most of the time slides are just incubating, thus freeing up time to perform the washing, reagent application and other functions on other slides.


One algorithm to accomplish simultaneous staining (sometimes referred to as the “random access” method) is to create a task and time schedule for each slide in the run, then perform each task on each slide when the schedule calls for it. The problem with this method is that incubation times will not be accurate if the instrument is busy performing a task on one slide when it is time to be washing another slide (thereby completing incubation on that slide). The variation in incubation times will be unpredictable since the total number of slides and the slide protocols vary.


Slide processing using the lock step algorithm insures that all incubation times are accurate and predictable irrespective of the number of slides processed or the variation in slide protocols. While incubation times are assured, the lock step algorithm implies that incubation times must be an increment of the fundamental incubation time period. In the above example the incubation period is two minutes, therefore total incubation times must be two, four, six, eight etc. minutes in duration. However, the preferred embodiment of the present invention uses a four minute incubation time. Generally this is not a particular limitation since typical incubation times are an order of magnitude longer than the fundamental incubation period.


Prior art staining systems typically include either convection or radiation to warm the samples above laboratory ambient temperatures for steps requiring elevated temperatures. Heating the slide improves staining quality by acceleration of the chemical reaction and can permit a reaction temperature more closely matching body temperature (about 37° C.) at which antibodies are designed to react. While such convection or radiant heating systems have been generally suitable for IHC, which is antibody based, they are less suitable for ISH, which is nucleic acid based and requires higher and more precise temperature control. In order to denature the DNA double helix of both the target sample and the probe so as to render them single stranded, the temperature must be raised above the melting point of the duplex, usually about 94° C. Precise temperature control is also required in ISH to effect probe hybridization at the desired stringency. The selected temperature must be low enough to enable hybridization between probe and target, but high enough to prevent mismatched hybrids from forming.


Hot air convection, conduction or radiant heat heating units typically employed with prior art automated tissue stainers do not permit the temperature of individual slides to be separately controlled. With prior art systems all of the slides are heated to the same temperature at any given time during the process. For example, U.S. Pat. No. 5,645,114 to Bogen et al. discloses a dispensing assembly adapted to carry a plurality of microscope slides. Individual slide holders containing resistive heating units are provided. However, with the assembly taught by Bogen et al., all of the slides would be heated to a common temperature because no means are disclosed for separate heating controls or for shielding slides from heat generated by adjacent slides.


Other difficulties frequently encountered in both IHC and ISH testing results from the manner in which the tissues are typically preserved. The mainstay of the diagnostic pathology laboratory has been for many decades the formalin-fixed, paraffin embedded block of tissue, sectioned and mounted upon glass slides. Fixation in such a preservative causes cross-linking of macromolecules, both amino acids and nucleic acids. These cross-linked components must be removed to allow access of the probe to the target nucleic acid and to allow the antibody to recognize the corresponding antigen. “Unmasking” the antigen and/or nucleic acid is typically accomplished manually with multiple pretreatment, protolytic digestion, and wash steps.


Prior to staining, complete removal of the paraffin is also required so that it does not interfere with antibody or probe binding. Deparaffinization normally is achieved by the use of two or three successive clearing reagents that are paraffin solvents such as xylene, xylene substitutes or toluene.


The foregoing discussion of the prior art largely derives from Richards et al. U.S. Pat. No. 6,296,809, assigned to Ventana Medical Systems, in which there is described apparatus and methods for automatically staining or treating multiple tissue samples mounted on microscope slides so that each sample can receive an individualized staining or treatment protocol even when such protocols require different temperature parameters. More specifically, there is described in the '809 patent apparatus comprising a computer controlled, bar code driven, staining instrument that automatically applies chemical and biological reagents to tissue or cells mounted or affixed to standard glass microscope slides. According to the '809 patent, a plurality of slides are mounted in a circular array on a carousel which rotates, as directed by the computer, to a dispensing location placing each slide under one of a series of reagent dispensers on a second rotating carousel positioned above the slides. Each slide receives the selected reagents (e.g. DNA probe) and is washed, mixed and/or heated in an optimum sequence and for the required period of time.


According to the '809 patent, individual slides are carried on thermal platforms radially mounted to the carousel. Sensors also mounted to the slide carousel, individually monitor and control each thermal platform separately. Apparatus made in accordance with the '809 patent is available commercially from Ventana Medical Systems, of Tucson, Ariz. as the DISCOVERY™ or BENCHMARK™ systems.


The present invention is a modification and improvement over the prior art including the apparatus and methods described in the '809 patent. More particularly, the present invention rather than bringing the slides to the reagent, stain, and wash stations, brings the reagent, stain and wash stations to fixedly positioned slides. That is to say, in the present invention the slides are fixedly positioned in the apparatus, and the various washing, staining and reagent fluids selectively delivered to the slides. Fixing the slides in position in the apparatus eliminates expensive and disposable dispensers, and simplifies wiring to the heaters, and also eliminates the potential that a slide may be dislocated by rapid start and stop movement of the slide carousel, which, in a worst case scenario could result in a domino or train-wreck effect where one dislocated slide hits the neighboring slide causing that slide to dislocate, and so forth. Additionally, maintaining the slides in fixed position eliminates inertial problems of a high-volume reagent and slide carousel. Thus, motors and bearings need not be so robust.


Further features and advantages of the present invention will be seen from the following detailed description, taken in conjunction with the accompanying drawings, wherein like numerals depict like parts, and wherein:





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of the apparatus of the present invention shown with the slide cabinet shell removed;



FIG. 2 is a perspective view of the apparatus of the present invention shown in conjunction with a computer and other instruments with which it operates;



FIG. 3 is a perspective view and FIG. 3a is an exploded view of details of the nozzle plate portion of the present invention;



FIG. 4 is an exploded view of details of the slide plate portion of the present invention;



FIGS. 5 and 6 are perspective views, from the top and the bottom, respectively, of portions of the slide plate portion of the present invention;



FIG. 7 is a perspective view of the reagent plate portion of the present invention;



FIG. 8 is a perspective view showing two reagent bottles of the present invention;



FIG. 9 is a top plan view of two reagent bottles of the present invention; and



FIG. 10 is a flow chart of the operation and control of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

Referring now in detail to the drawings wherein like parts are designated by like reference numerals throughout, there is illustrated in FIG. 1 a perspective view of the molecular pathology apparatus according to the present invention which is designated generally by reference numeral 10. For the purposes of clarity, several of the reagent bottles, as well as the cabinet shell, and liquid and air supply tubing and electrical wiring are omitted from the drawings. Apparatus 10 is designed to automatically stain or otherwise treat tissue mounted on microscope slides with nucleic acid probes, antibodies, and/or other reagents in a desired sequence, time and temperature. Tissue sections so stained or treated are then to be viewed under a microscope by a medical practitioner who reads the slide for purposes of patient diagnosis, prognosis, or treatment selection.


In a preferred embodiment, apparatus 10 functions as one component or module of a system 12 (FIG. 2) which also comprises a host computer 14 preferably a personal computer, monitor 16, keyboard 18, mouse 20, bulk fluid containers 22, waste container 23 and related equipment. Additional staining modules or other instruments may be added to system 12 to form a network with computer 14 functioning as a server. Alternatively, some or all of these separate components could be incorporated into apparatus 10 making it a stand-alone instrument. Referring also to FIGS. 3-7, as set forth in greater detail below, a plurality of slide platforms 50 are mounted radially about a center point 32 of drawer 34 upon which standard glass slides 60 with tissue samples may be placed. Drawer 34 is preferably constructed of stainless steel and is slidably mounted in housing 30 on rails 40 or the like. The temperature of each slide may be individually controlled by means of sensors and a microprocessor, i.e. as taught in the above-mentioned '809 patent.


Each of the slide platforms 50 is connected through individual wires and a wiring harness (not shown) to a microprocessor. A feature and advantage of the present invention which results from fixedly mounting the slide platforms in drawer 34 is that each of the heaters and thermal sensors may be hardwired thereby eliminating the need for a slip ring assembly or rotor couplings, as well as complex stepping motors, etc. for locating and positioning a rotating slide carousel as required in prior art devices. Also, the possibility that a slide or slides may be shifted or dislocated during rapid start and stop rotation of the slide carousel is eliminated.


In a particularly preferred embodiment, a plurality of slots or channels are formed on the top surface of each of the slide heaters, i.e. the interface surface between the slide heater and the slide, for gathering and venting gas bubbles as may form during heating, i.e. in accordance with co-pending U.S. application Ser. No. 09/953,417, filed Sep. 11, 2001, and assigned to the common assignee, which disclosure is incorporated herein by reference.


Referring also to FIGS. 1, 2, 5 and 6, drawer 34 includes a circular pan 35 having a peripherial wall 36 serving as a splash guard, a peripheral trough 37 and a central drain 38, i.e. at center point 32, both connected to drain lines (39) which in turn are connected to waste container 23. Drawer 34 is slidably mounted in housing 30 on rails 40. Rails 40, in a preferred embodiment, comprise three piece telescoping rails so that the drawer 34 may be slid clear of housing 30 to permit access to all of the slide platforms 50 for slide loading and removal. A damping means 42 such as a pneumatic means, electromotive means, mechanical spring damper or the like preferably is provided to smooth movement of the drawer whereby to avoid possible dislodging of slides, particularly when the drawer is closed. Also, in a preferred embodiment of the invention, rails 40 are supported on a lift mechanism such as pneumatic cylinders 52 (see FIG. 1), which automatically index to permit the rails 40 to move up and down so that the drawer 34 may be dropped to permit wall 36 to clear the nozzle plate 100 when the drawer is slid in and out of the apparatus.


Slide drawer 34 is divided into thirty-five equal pie-shaped sections 70. Thirty of the pie-shaped sections 70 are occupied by slide platforms 50 while the five remaining pie-shaped sections 70A (FIG. 4) at the rear of the drawer are devoid of slide platforms 50. In other words, a row of thirty slide platforms 50 are radially mounted on drawer 34 and evenly spaced from one another, except at the ends of the row.


However, the invention is not limited to thirty active slide locations, and more or fewer slide locations may be employed. An alternative embodiment may be implemented by aligning the platforms 50 linearly, which results in potentially limitless number of platforms.


Referring to FIGS.1 and 3, a nozzle plate 100 is concentrically and rotatably mounted above slide drawer 34. Nozzle plate 100 is mounted on a shaft (not shown) supported by a bridge 110, and driven by a computer controlled stepping motor and drive belt (not shown), and rotates 185° plus or minus from a home position 104 at the rear of the drawer. The computer controlled stepper motor and drive belt are conventional in this art. Accordingly, details are omitted for the sake of clarity.


Nozzle plate 100 carries the various slide treatment stations, other than the reagent dispensing station. Thus, nozzle plate 100 carries dual rinse nozzle block 102, volume adjust/stringency block 103, Liquid Coverslip™ evaporation inhibitor liquid application block 104, vortex mixer air jet block 106, jet drain knives 108, and the like, all for preparing a slide for staining, stain removal, and the like, and to clear bar codes 110 carried on the slides, and a bar code reader 109, all as described in detail in U.S. Pat. No. 5,654,200 to Copeland et al, which disclosure is incorporated herein by reference. In other words, nozzle plate 100 carries all of the functions for slide preparation, cleaning, reagent mixing, Liquid Coverslip™ application, etc. other than reagent application, as described in the '200 patent to Copeland et al., plus wash stations 121, 122 for the reagent application probes as will be described in detail below.


Preferably, but not necessarily, the various rinse nozzle blocks, vortex mixer air jet blocks, air knives, etc. are arranged adjacent to one another so that the nozzle plate may be indexed and advanced in a “lock-step” manner to sequentially treat a slide according to an accepted protocol. For example, air knives 108 may be arranged immediately adjacent rinse nozzle blocks 106 so that nozzle plate 100 may be advanced in “lock step” manner past a selected slide, and the slide rinsed and fluid stripped, etc. Also, if desired, vortex mixer air jet blocks 106 may be oriented to impinge simultaneously on two adjacent slides.


For the sake of clarity, fluid and air supply tubing for the several slide treatment stations have been omitted from the drawings. It will be understood, however, that the fluid and air supply tubing are made long enough to permit 185° rotation of the valve plate so that each slide treatment station can reach each slide 60. A pair of wash stations 121, 122 spaced two thirty-fifths of a revolution (approximately 20.572°) apart as will be described in detail hereinafter, are also attached to and radially extend beyond the periphery of the nozzle plate 100, and rotate with the nozzle plate 100.


Reagent plate 300 is fixedly mounted to arch 110 vertically above nozzle plate 100, which arch in turn is fixedly mounted within housing 30. A plurality of reagent bottles 302 are removably mounted within recesses 304 formed equally spaced adjacent the periphery of reagent plate 300. In the illustrated embodiment, a total of thirty-five reagent bottles are mounted on the reagent plate, spaced approximately one thirty-fifth (approximately 10.286°) apart.


The reagents may include any chemical or biological material conventionally applied to slides including nucleic acid probes or primers, polymerase, primary and secondary antibodies, digestion enzymes, pre-fixatives, post-fixatives, readout chemistry, counterstains, and the like.


Referring also to FIG. 8, the reagent bottles 302 each comprise a cylindrical hollow body 305 closed at the bottom end by an integrally formed bottom wall (not shown). Each bottle 302 includes an integrally formed bracket 306 which serves to maintain the bottles 304 at a desired height in reagent plate 300, and which serves also to permit the stringing together of a plurality of like bottles 302. Accordingly, each bracket 302 includes a hinge element 308 for cooperating with a hinge element 310 of an adjacent bottle 302. In the illustrated embodiment, hinge elements 308 and 310 are shown as conventional pin-hinges in which the upper hinge 308 includes a pin 312 which fits into the lower hinge 310, i.e. similar to a conventional door hinge. However, bottles 302 may be hinged together in a variety of ways.


Bracket 306 preferably includes a flat surface 314 upon which is carried a bar code 316 for identifying the contents of the bottle 302. Bottles 302 also include an insert 318 having a tapered top surface 320 fitted in the top end of the bottles for locating a reagent transfer probe as will be described in detail hereinafter, and a cap 322 which may be either twist or snap-fitted to the bottle 302 for sealing the bottle 302.


Making brackets 306 attachable to one another permits a lab worker to assemble a chain of reagents for use, and also to remove the chain of reagents so that the reagents may be refrigerated, for example, overnight when not in use.


Referring next to FIG. 9, the side walls 324 of brackets 306 are tapered so that a pie-shaped space 326 is formed between two bottles when two bottles are fastened together in a string, and mounted in recesses 104 in the reagent plate 300, thereby exposing holes 328 formed through reagent plate 300. Holes 328 are formed in the same concentric circle as recesses 304, and are spaced equidistant between adjacent recesses 304. The purpose of pie-shaped spaces 326 and holes 328 is to provide clearance for reagent transfer probes 402, 404 as will be described in detail below.


Referring again to FIG. 1, an arm 400 is rotatably mounted on arch 405 concentrically above reagent plate 300, and carries a pair of reagent transfer probes 402, 404 located at the distal end of arm 400 and spaced approximately 10.286° apart. Arm 400 also carries a bar code reader 406 for reading bar codes 316 on the reagent bottles. Arm 400 is rotatably driven by a computer driven stepping motor (not shown), and rotates plus or minus 185° in either direction from a home position 410.


Reagent transfer probes 402 and 404, which are identical to one another, preferably comprise automatic pipette metering/dispensing pick-up devices designed to aspirate or “sip” reagent from a reagent bottle, move to a slide, and then “spit” or deposit the reagent onto the slide. “Sip” and “spit” automatic pipette/metering dispensing pick-up devices are described in published PCT Application No. PCT/US99/04379, which disclosure is incorporated herein by reference. Reagent transfer probes 402 and 404 are carried on the distal end of arm 400 and are spaced from one another so that when one of the probes, e.g. probe 402 is located centrally over a slide 60, the other reagent transfer probe 404 may be centrally positioned over one of the two probe wash stations 121 or 122. A pneumatic cylinder (not shown) selectively raises and lowers probes 402 and 404 into one of the following positions: a raised transport position above the tops of the bottles 302 where the arm 400 is free to rotate; a reagent drawing position wherein one of the probes is inserted into a selected reagent bottle 302 wherein a measured amount of reagent may be drawn into the probe; a reagent dispensing position wherein a reagent transfer probe containing reagent is disposed in the pie-shaped space 326 between two reagent bottles, above a selected slide to dispense reagent thereon; and a cleaning position wherein the other probe, i.e. the probe not being used to dispense reagent, is operatively disposed in one of probe washing stations 121 or 122. While the apparatus of the present invention could be made with only a single reagent transfer probe, providing two spaced reagent transfer probes essentially doubles cycle speed since reagent metering may be accomplished using one of the two reagent transfer probes while the other of the two reagent transfer probes is going through the wash cycle as will be described below. That is to say, while one of the reagent transfer probes, e.g. reagent transfer probe 402 is dispensing reagent onto a slide, the other reagent transfer probe, i.e. idle reagent transfer probe 404 may be lowered to a probe wash station 121 where the idle reagent transfer probe may be rinsed inside and out at the same time.


Referring to FIG. 10, the overall process is as follows:


A plurality of specimen-bearing slides 60 are mounted on the slide platforms 50, selected reagent bottles 302 mounted in the reagent plate, the slide drawer is closed and the slide bar codes are read. The computer than downloads the run steps for the entire run, the nozzle plate 100 is indexed to the first slide, and the slide is washed and prepared for staining or other treatment in accordance with the pre-programmed run steps by advancing the nozzle plate in “lock-step” manner. In the meanwhile, probe arm 400 is rotated to the appropriate reagent bottle 302, one of the two reagent transfer probes 402 or 404 is indexed over the selected reagent bottle, and the probe lowered to aspirate a measured amount of the desired reagent. The reagent-containing transfer probe is then raised, and the arm 400 moved to the selected slide where the loaded reagent transfer probe is lowered to just over the slide, and the reagent dispensed on the slide. In the meanwhile, the idle reagent transfer probe is lowered into one of the washing stations 121 or 122, wherein the reagent transfer probe is washed inside and out. Both reagent transfer probes 402 and 404 are then raised, and the process repeated, but using the reagent transfer probe just cleaned in the previous step to aspirate and dispense reagent onto the next slide. As before, simultaneously with dispensing the reagent onto the slide as in the previous case, the idle reagent transfer probe is washed while the active reagent transfer probe is dispensing reagent onto the new slide.


The foregoing steps are repeated until all of the slides are processed. For convenience, in the illustrated embodiment, the dwell time at each slide station is approximately six and two-thirds seconds. This comes from dividing a four minute cycle time into thirty-six time spaces, one time space for each of the thirty slide positions plus five blank slide positions, plus one “virtual” time space for returning the arm 400 from the last slide position to the first slide position. The virtual slide position allows the nozzle plate to return to the other end of its travel range in an uninterrupted fashion.


The staining algorithm used on the aforesaid Ventana systems avoids the above problem by using a “lock step” method. The lock step algorithm requires that the nozzle plate which holds the processing functions be rotated one slide position index every n seconds, termed the slide index time. The slide index time is preferably as short as possible but long enough that the function that requires the longest time can be completed within the index time. Index times are usually on the order of several seconds. The time for one complete rotation of the nozzle plate, termed the fundamental incubation period, will then be n times the number of slide positions. (For example, if the slide index time is six seconds and there are twenty slide positions, the incubation time period will be 120 seconds or two minutes.)


Throughout the entire run the nozzle plate is indexed one slide position every n seconds. After the index, the system checks the schedule to see if any of the slides at each of the processing stations require the function of that, station. For example, if the slide at the washing station is scheduled for washing, that slide is washed. Similarly if the slide at the reagent application station is scheduled for the application of a new reagent, then the new reagent is applied.


The above-described invention has several advantages over the prior art. For one, making the slide plate fixed in position reduces the possibility of a slide being dislocated during the rapid start-stop rotational movement of a slide carousel. Also, employing two transfer syringes insures better cleaning of transfer syringes without increasing cycle time. Also, using vials or bottles for reagents eliminates the prior art's reliance on complex and costly dispensers.


Also, since none of the moving elements, i.e. nozzle plate 100 and probe support arm 400 need travel more than plus or minus 185° in either direction, all electrical connections, and air and fluid-connections can be achieved without the need for slip ring or rotary connections, since the hoses and wires are quite capable of taking twistings of 185° plus.


The instrumentation described herein may or may not have the ability to continuously rotate the nozzle plate. The nozzle plate may need to return to a starting position before rotation has exceeded 360 degrees. This may also be required when the slides are rotated on a carousel and the processing functions are fixed above the slides. Similarly, other non rotating designs are possible such as linear or two dimensional configurations. In these cases there will be a requirement to move the slides or processing functions back to the original starting position during the staining run. In most cases it is likely that the time required to do this will exceed the index time which violates the fundamental requirement of the lock step algorithm. The lock step algorithm can still be used by introducing the concept of a “virtual slide”. The virtual slide is added to the-total number of slides so that the index time period assigned to the virtual slide may be used to move the slides or processing stations back to the starting position. Thus accurate and predictable incubation times are maintained.


While a preferred embodiment of the invention has been described, the invention is susceptible to-modification. For example, instead of using one or a pair of transfer syringes on an overhead arm, the reagent carousel could carry a plurality of micro-delivery reagent fluid dispensers such as described in U.S. Pat. Nos. 5,232,664 or 5,654,200 or 6,093,574 or 6,192,945. Moreover, while the use of individually heated thermal platforms is preferred, the slides may be heated using conventional convection heating techniques. Still other changes may be made without departing from the spirit and scope of the invention.

Claims
  • 1. A method for processing a slide having a biological sample thereon comprising the steps of: (a) preparing a slide for biological treatment with a reagent;(b) moving a first reagent dispenser to a first reagent bottle;(c) aspirating a pre-selected volume of reagent from the first reagent bottle into the first reagent dispenser;(d) moving the first reagent dispenser to the slide;(e) dispensing the pre-selected volume of reagent from said first reagent dispenser onto the slide;(f) preparing a second slide for treatment with a reagent;(g) cleaning the first reagent dispenser;(h) moving a second reagent dispenser to a selected reagent bottle which may be the same or different from the first reagent bottle;(i) aspirating a pre-selected amount of reagent selected in the preceding step (h) into the second reagent dispenser;(j) moving the second reagent dispenser to said second slide;(k) dispensing said pre-selected volume of reagent from said second reagent dispenser onto said second slide;(l) cleaning the second reagent dispenser; and(m) repeating steps (h)-(l) while maintaining the slide in a fixed position, wherein the first reagent dispenser is cleaned while the second reagent dispenser is employed to dispense reagent onto a second slide, and vice versa.
  • 2. The method according to claim 1, wherein said first and second reagent dispensers each comprise a robotic syringe, and reagent is taken up by aspiration.
  • 3. The method according to claim 1, including the step of heating the slide before, during or following treatment with a reagent.
  • 4. The method according to claim 1, including the step of applying a cleaning reagent or wash solution onto said slide.
  • 5. The method according to claim 4, including the step of heating the slide before, during or following application of said cleaning reagent or wash solution.
  • 6. The method according to claim 1, including the step of leveling and/or stripping reagent from the slide by means of an air jet or air knife.
  • 7. The method according to claim 1, including the step of applying a cover fluid to the slide.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority from U.S. Provisional Application Ser. No. 60/350,273, filed Nov. 2, 2001. This Application is a divisional of U.S. application Ser. No. 10/283,639, filed Oct. 30, 2002 now U.S. Pat. No. 7,270,785.

US Referenced Citations (200)
Number Name Date Kind
3219416 Natelson Nov 1965 A
3574064 Binnings et al. Apr 1971 A
3650437 Binnings et al. Mar 1972 A
3665148 Yasenchak et al. May 1972 A
3695281 Leon Oct 1972 A
3853092 Amos et al. Dec 1974 A
3854703 Gibbs et al. Dec 1974 A
3900289 Liston Aug 1975 A
3977568 Smith Aug 1976 A
3979576 Janson Sep 1976 A
4013038 Rogers et al. Mar 1977 A
4043292 Rogers et al. Aug 1977 A
4058367 Gilford Nov 1977 A
4092952 Wilkie et al. Jun 1978 A
4245967 Busselet Jan 1981 A
RE30730 Duff Sep 1981 E
4286637 Wilson Sep 1981 A
4296069 Smith et al. Oct 1981 A
4298571 DiFulvio et al. Nov 1981 A
4346056 Sakurada Aug 1982 A
4358470 Rasmussen Nov 1982 A
4384193 Kledzik et al. May 1983 A
4406547 Aihara Sep 1983 A
4430299 Horne Feb 1984 A
4447395 Englar et al. May 1984 A
4455280 Shinohara et al. Jun 1984 A
4484293 Minucciani et al. Nov 1984 A
4528159 Liston Jul 1985 A
4539855 Jacobs Sep 1985 A
4543236 Von Gise Sep 1985 A
4577514 Bradley et al. Mar 1986 A
4629862 Kitagawa et al. Dec 1986 A
4635791 Jackson et al. Jan 1987 A
4647431 Sekine et al. Mar 1987 A
4648023 Powell Mar 1987 A
4659971 Suzuki et al. Apr 1987 A
4670974 Antoszewski et al. Jun 1987 A
4678752 Thorne et al. Jul 1987 A
4681741 Hanaway Jul 1987 A
4695430 Coville et al. Sep 1987 A
4708886 Nelson Nov 1987 A
4727409 Conner et al. Feb 1988 A
4727494 Buote Feb 1988 A
4729661 Bell Mar 1988 A
4731335 Brigati Mar 1988 A
4738824 Takeuchi Apr 1988 A
4764342 Kelln et al. Aug 1988 A
4774055 Wakatake et al. Sep 1988 A
4777020 Brigati Oct 1988 A
4781891 Galle et al. Nov 1988 A
4795710 Muszak et al. Jan 1989 A
4798706 Brigati Jan 1989 A
4801431 Cuomo et al. Jan 1989 A
4805469 Commarmot Feb 1989 A
4807152 Lane et al. Feb 1989 A
4815978 Mazza et al. Mar 1989 A
4835711 Hutchins et al. May 1989 A
4837159 Yamada Jun 1989 A
4843566 Gordon et al. Jun 1989 A
4844868 Rokugawa Jul 1989 A
4847208 Bogen Jul 1989 A
4852001 Tsushima et al. Jul 1989 A
4855109 Muraishi et al. Aug 1989 A
4858155 Okawa et al. Aug 1989 A
4865986 Coy et al. Sep 1989 A
4895706 Root et al. Jan 1990 A
4896269 Tong Jan 1990 A
4902481 Clark et al. Feb 1990 A
4919887 Wakatake Apr 1990 A
4927765 Saxon et al. May 1990 A
4933146 Meyer et al. Jun 1990 A
4935875 Shah et al. Jun 1990 A
4961906 Andersen et al. Oct 1990 A
4964544 Hanna et al. Oct 1990 A
4965049 Lillig et al. Oct 1990 A
4971913 Manabe et al. Nov 1990 A
4975250 Mordecki Dec 1990 A
4979093 Laine et al. Dec 1990 A
4979128 Seki et al. Dec 1990 A
4985206 Bowman et al. Jan 1991 A
5002736 Babbitt et al. Mar 1991 A
5023187 Koebler et al. Jun 1991 A
5035866 Wannlund Jul 1991 A
5040123 Barber et al. Aug 1991 A
5051238 Umetsu et al. Sep 1991 A
5073504 Bogen Dec 1991 A
5075079 Kerr et al. Dec 1991 A
5084242 Sakuma et al. Jan 1992 A
5089229 Heidt et al. Feb 1992 A
5093557 Lok et al. Mar 1992 A
5096670 Harris et al. Mar 1992 A
5105066 Houdy et al. Apr 1992 A
5116496 Scott May 1992 A
5122342 McCulloch et al. Jun 1992 A
5122959 Nathanson et al. Jun 1992 A
5148370 Litt et al. Sep 1992 A
5154889 Muraishi Oct 1992 A
5168453 Nomaru et al. Dec 1992 A
5180606 Stokes et al. Jan 1993 A
5207987 Kureshy et al. May 1993 A
5213764 Kerr et al. May 1993 A
5229074 Heath et al. Jul 1993 A
5231029 Wootton et al. Jul 1993 A
5232664 Krawzak et al. Aug 1993 A
5233533 Edstrom et al. Aug 1993 A
5246665 Tyranski et al. Sep 1993 A
5273905 Muller et al. Dec 1993 A
5280156 Niori et al. Jan 1994 A
5282149 Grandone et al. Jan 1994 A
5304347 Mann et al. Apr 1994 A
5311426 Donohue et al. May 1994 A
5314825 Weyrauch et al. May 1994 A
5316452 Bogen et al. May 1994 A
5316726 Babson et al. May 1994 A
5334353 Blattner Aug 1994 A
5352612 Huber et al. Oct 1994 A
5355439 Bernstein et al. Oct 1994 A
5355695 Kawaguchi et al. Oct 1994 A
5356814 Carrico, Jr. et al. Oct 1994 A
5358691 Clark et al. Oct 1994 A
5376313 Kanewske, III et al. Dec 1994 A
5402350 Kline Mar 1995 A
5424036 Ushikubo Jun 1995 A
5425918 Healey et al. Jun 1995 A
5428470 Labriola, II Jun 1995 A
5431309 Ophardt Jul 1995 A
5439645 Saralegui et al. Aug 1995 A
5439649 Tseung et al. Aug 1995 A
5446652 Peterson et al. Aug 1995 A
5475610 Atwood et al. Dec 1995 A
5479581 Kleinschnitz Dec 1995 A
5496518 Arai et al. Mar 1996 A
5512248 Van Apr 1996 A
5523056 Miller Jun 1996 A
5525302 Astle Jun 1996 A
5525515 Blattner Jun 1996 A
5575973 Choi et al. Nov 1996 A
5576215 Burns et al. Nov 1996 A
5578455 Tosa et al. Nov 1996 A
5589649 Brinker et al. Dec 1996 A
5595707 Copeland et al. Jan 1997 A
5597733 Bell et al. Jan 1997 A
5601141 Gordon et al. Feb 1997 A
5629201 Nugteren et al. May 1997 A
5639665 Arai et al. Jun 1997 A
5645114 Bogen et al. Jul 1997 A
5646046 Fischer et al. Jul 1997 A
5646049 Tayi Jul 1997 A
5650327 Copeland et al. Jul 1997 A
5654199 Copeland et al. Aug 1997 A
5654200 Copeland et al. Aug 1997 A
5656493 Mullis et al. Aug 1997 A
5695718 Imai et al. Dec 1997 A
5736105 Astle Apr 1998 A
5737498 Murray Apr 1998 A
5819842 Potter et al. Oct 1998 A
5839091 Rhett et al. Nov 1998 A
5861094 Gochde Jan 1999 A
5875286 Bernstein et al. Feb 1999 A
5879944 Komatsu Mar 1999 A
5909674 Schaffer et al. Jun 1999 A
5947167 Bogen et al. Sep 1999 A
5948359 Kalra et al. Sep 1999 A
5975740 Lin et al. Nov 1999 A
5985672 Kegelman et al. Nov 1999 A
6054099 Levy Apr 2000 A
6068393 Hutchins et al. May 2000 A
6092695 Loeffler Jul 2000 A
6093574 Druyor-Sanchez et al. Jul 2000 A
6096271 Bogen et al. Aug 2000 A
6180060 Green et al. Jan 2001 B1
6180061 Bogen et al. Jan 2001 B1
6183645 DeWitt Feb 2001 B1
6183693 Bogen et al. Feb 2001 B1
6192945 Ford et al. Feb 2001 B1
6193933 Sasaki et al. Feb 2001 B1
6241947 Komatsu et al. Jun 2001 B1
6296764 Guirguis et al. Oct 2001 B1
6296809 Richards et al. Oct 2001 B1
6352861 Copeland et al. Mar 2002 B1
6372144 Vassarotti Apr 2002 B1
6495106 Kaira et al. Dec 2002 B1
6531094 Seto et al. Mar 2003 B2
6537818 Richards et al. Mar 2003 B2
6541261 Bogen et al. Apr 2003 B1
6582962 Richards et al. Jun 2003 B1
6594537 Bernstein et al. Jul 2003 B1
6673620 Loeffler et al. Jan 2004 B1
6783733 Bogen et al. Aug 2004 B2
6827900 Thiem et al. Dec 2004 B2
20010004449 Suzuki et al. Jun 2001 A1
20010016358 Osawa et al. Aug 2001 A1
20010055545 Takii et al. Dec 2001 A1
20020037239 Komatsu Mar 2002 A1
20020054830 Bogen et al. May 2002 A1
20030032191 Hilson et al. Feb 2003 A1
20030203493 Lemme et al. Oct 2003 A1
20040191128 Bogen et al. Sep 2004 A1
20040241050 Bogen et al. Dec 2004 A1
20070086917 Lemme et al. Apr 2007 A1
Foreign Referenced Citations (19)
Number Date Country
0 201 780 Nov 1986 EP
0 240 134 Feb 1987 EP
0517835 Feb 1996 EP
1 052 497 Nov 2000 EP
1 052 497 Jan 2003 EP
2 239 167 Jan 1967 FR
2 528 122 Apr 1982 FR
2143205 Feb 1985 GB
2 216 259 Oct 1989 GB
55-107957 Feb 1979 JP
55-014157 Mar 1980 JP
63-208761 Aug 1988 JP
04-356845 Dec 1992 JP
WO 8700086 Jan 1987 WO
WO 8802865 Apr 1988 WO
WO 9113335 Sep 1991 WO
WO 9307486 May 1993 WO
PCTUS9816604 Dec 1998 WO
WO 9943434 Sep 1999 WO
Related Publications (1)
Number Date Country
20060093520 A1 May 2006 US
Provisional Applications (1)
Number Date Country
60350273 Nov 2001 US
Divisions (1)
Number Date Country
Parent 10283639 Oct 2002 US
Child 11293489 US